New research by NIAAA scientists shows that an experimental drug that targets molecular sites in the liver and other tissues without acting on identical sites in the brain, holds promise as an effective treatment for obesity and its complications. In the July 26, 2012 issue of the journal Cell Metabolism, researchers led by NIAAA Scientific Director George Kunos, M.D., Ph.D...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
The medication naltrexone and up to 20 sessions of alcohol counseling by a behavioral specialist are equally effective treatments for alcohol dependence when delivered with structured medical management, according to results from "Combining Medications and Behavioral Interventions for Alcoholism" (The COMBINE Study). Results from the National Institutes of Health-supported study show that patients who received naltrexone, specialized alcohol counseling, or...
On November 17, join the Addiction Policy Forum and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for a Facebook Live Event: "Choosing Quality Alcohol Treatment: A Conversation With the Developers of the NIAAA Alcohol Treatment Navigator" Speakers: Dr. Patricia Powell, NIAAA Deputy Director Dr. Lori Ducharme, Navigator Lead Developer Moderator: Mark O’Brien, VP of State and Local Affairs...
The effectiveness of an experimental treatment for alcoholism depends on the genetic makeup of individuals who receive it, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. A report of the findings appears online in the American Journal of Psychiatry. “This study represents an important milestone...
Flying footballs, couch potato mice, and what can happen with explosive-propelled iron spikes are just a few of the interactive tools that scientists from the National Institutes of Health used to teach young people about the amazing human brain at the National Museum of Health and Medicine in Silver Spring, Md., on March 14 and 15. The NIH activities are...
Simi Valley, California. Neuroscience research, including studies of alcohol actions on the brain, biological and behavioral mechanisms of chronic drinking, mechanisms of brain damage and cognitive dysfunction, and animal and human genetic studies on the role of genes in mediating behavioral responses to alcohol, is a key to optimal treatments and targeted prevention among persons at risk for alcoholism (alcohol...
NIH-funded study says five-marker genotype panel can guide ondansetron use An experimental treatment for alcohol dependence works better in individuals who possess specific combinations of genes that regulate the function and binding of serotonin, a brain chemical affected by the treatment, according to a study supported by the National Institutes of Health. A report of the finding appears online in...
Neurokinin-1 receptors (NK1R) are highly expressed in brain areas involved in stress responses and drug reward. In recent years, mounting research evidence has suggested that they may help regulate important aspects of alcohol use. In a new study, researchers at the NIAAA report that a compound that blocks NK1R suppresses alcohol drinking in mice. NIAAA Clinical Director Markus Heilig, M.D...
To listen to this discussion, visit https://nih.webex.com/nih/onstage/g.php?MTID=ec32f727d4423c79ab62e1aac9… Hosted by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Taking Stock of Advancing Technology for the Treatment and Prevention of Alcohol Use Disorder Chair - Ian Colrain 9:00 - 9:15 Introductions Discussions 9:15 - 9:40 Alcohol success stories. A good place to start is to review some of the progress that...